Nicola Roverato, Phd Email & Phone Number

Lugano, TI, CH

Switzerland

Supporting and adapting Solentim technologies to achieve best-in-class workflows within the Antibody production, Gene Therapy and Cell Therapy areas.

Switzerland

- Connect the FAS team to the FSE, PM, R&D and Sales teams- SME Cell Line Development- Internal trainings- Demo organization for the team- Optimization of demo and training process- Product Development

Switzerland

Supporting scientists to achieve a top-level Bioprocessing workflow. The final aim is to provide instruments and know-how to optimize the conditions for the production of Cell Therapies, Antibody Therapies and high-quality iPSCs.- Demonstrations and trainings - Customer support- Commercial support to Account Managers and Business developers.

Constance, Baden-Württemberg, Germany

• Validating new drug targets and potential new drugs to regulate the protein degradation associated to the inflammation that accompanies the immune response:The focus of this research is to study how targeting the.
• Project management: planning and coordination of the studies, guiding the projects to match the targets of the lab.
• Supervision of external collaborations with known experts in the biomedical field.
• Training and mentoring: providing technical and theoretical training and supervision to master students, PhD students and other research professionals.
• trouble-shooting
• Establishment of cross-functional works with Companies and Facilities outside the laboratory.

Constance, Baden-Württemberg, Germany

• Fellow in Human Biology Finding novel insights into how neuro-inflammation triggers Parkinson´s disease.The focus of this research has been to find and validate new drug targets to ameliorate the inflammatory.
• Discovery of targets through biochemical, molecular biological, cell biological and immunological studies (focusing on protein degradation and mitochondrial biology)
• Target validation, in-vivo/in-vitro pharmacology.
• Learning of advanced molecular biology, biochemical and molecular immunological techniques.
• Technical training and supervision of Bachelor and Master Students.
• Independent management of 3 parallel projects.

Munich, Bavaria, Germany

Pharmacological in vivo/in vitro studies on the effect of the RNA-based drug “Spiegelmer” on the Acute Kidney Injury.The focus of my research was the inhibition of the chemokine CCL2 by a "Spiegelmer" oligonucleotides-based drug. Acute Kidney injury was my main topic, with particular interest in the disease patho-physiology. The aim of the study was to.

Phd Human Biology, Molecular Biology, Immunology, Summa Cum Laude

Activities and Societies: Doctoral fellow of Human Biology (Immunology) Department of Immunology, Faculty of Biology During this period, I.

Master Thesis, Immunology

Activities and Societies: The aim of the study was to better understand the process of acute kidney injury and glomerular damage under.

Master'S Degree, Pharmaceutical Chemistry And Technology, Distinction